Botswana
9 Vaccines Approved for Use in Botswana
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: xinhuanet.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: bomra.co.bw
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: xinhuanet.com
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
6 trials in 1 country
Approval Source: xinhuanet.com
Inactivated
Bharat Biotech
Covaxin
Approved in 14 countries
16 trials in 2 countries
Approval Source: bomra.co.bw
Inactivated
Protein Subunit
Biological E Limited
Corbevax
Approved in 2 countries
7 trials in 1 country
Approval Source: bnnbloomberg.ca
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: bomra.co.bw
1 in Clinical Trials in Botswana
RNA
Moderna
Spikevax
Approved in 88 countries
70 trials in 24 countries